Sam­sung Bi­o­log­ics to sep­a­rate man­u­fac­tur­ing and biosim­i­lar busi­ness­es

Sam­sung Bi­o­log­ics is split­ting apart its con­tract man­u­fac­tur­ing and biosim­i­lar de­vel­op­ment ac­tiv­i­ties in a bid to en­hance their com­pet­i­tive­ness.

Sam­sung Bio will be­come a pure …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA